Cue Biopharma IND application for cancer candidate CUE-102 accepted by FDA - Seeking Alpha

Retrieved on: 2022-05-11 13:12:16

Tags for this article:

Click the tags to see associated articles and topics

Cue Biopharma IND application for cancer candidate CUE-102 accepted by FDA - Seeking Alpha. View article details on hiswai:

Excerpt

The U.S. FDA has accepted an Investigational New Drug application from Cue Biopharma (CUE) for CUE-102, under investigation initially for gastric, ...

Article found on: seekingalpha.com

View Original Article